Khazani, Yosra
Manesh, Sirous Fathi
Shaseb, Elnaz
Sarbakhsh, Parvin
Funding for this research was provided by:
the Vice-Chancellor for Research and Technology of Tabriz University of Medical Sciences (68967)
Article History
Received: 15 March 2024
Accepted: 30 January 2025
First Online: 26 February 2025
Declarations
:
: This study is a secondary study based on the data of the primary study that was a clinical trial. For the primary study, ethical approval had been obtained from the Ethics committee of Tabriz University of Medical Sciences (ethics No. TBZMED.REC.1398.334). Also, the study protocol was registered at the Iranian Registry of Clinical Trials (IRCT) (IRCT20180404039187N4) prior to subject recruitment. Current secondary study was approved by the Ethics Committee of Tabriz University of Medical Sciences as well (ethics No. IR.TBZMED.REC.1401.577).The study adhered to ethical guidelines, including the principles outlined in the Helsinki Declaration of 1975 and the European Convention of Oviedo dated 4 April 1997, which safeguards human rights and dignity concerning the applications of biology and medicine. Before participating in the study, the parents or legal guardians of all included individuals provided written informed consent. The results obtained were maintained in an anonymous manner to ensure confidentiality.
: Not applicable.
: The authors declare no competing interests.